Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Neoplastic Cells, Circulating, Oropharyngeal Neoplasms

NCT06678724 2026-02-24

Establishment of a Microfluidic Based Liquid Biopsy Platform for Recurrent/Metastatic Head and Neck Cancers Prognostication Using NK Cell IFN-γ Expression and CTM Correlation With DS-SACA Chip

Recruiting

30 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplastic Cells, Circulating

NCT07396259 2026-02-09

Predicting Clinical Efficacy of Immunotherapy Using Pre-treatment andContinuousMonitoring of PD-L1 TPS/CPS on CTCs, and Immunity Exhaustion Scores

Recruiting

150 enrolled

Head & Neck

Head and Neck Neoplasms, Neoplastic Cells, Circulating

NCT04544969 2025-01-28

Detecting Chemosensitivity and Predicting Treatmemt Efficacy With CTCs in mNPC

Recruiting

50 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Neoplastic Cells, Circulating

NCT06755762 2025-01-01

Using a 3D Culture Model for Circulating Tumor Cells Combined With Molecular Bioassays in Patients With HNSCC Cancer

Recruiting

88 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Neoplastic Cells, Circulating

NCT03772496 2019-09-17

CTCs

Phase NA Unknown

200 enrolled

Head & Neck

Neoplastic Cells, Circulating, Thyroid Nodule

NCT03917537 2019-04-25

WGA in Platinum-refractory HNSCC Underwent Nivolumab

Unknown

80 enrolled

Head & Neck

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Neoplastic Cells, Circulating

NCT03917524 2019-04-17

CTC

Unknown

180 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Mouth Neoplasms, Neoplastic Cells, Circulating

NCT02892786 2018-08-08

CTCVADS

Phase NA Completed

40 enrolled

Head & Neck

Head and Neck Neoplasms, Neoplastic Cells, Circulating

NCT02791607 2017-08-10

The Clinical Relevance of P16 Expressing CTCs Detection Comparing With HPV Infection in Cancer Tissue in HNSCC Patients.

Unknown

150 enrolled

Head & Neck

Death, Head and Neck Neoplasms, Neoplastic Cells, Circulating, Neoplasm Metastasis, Recurrence

NCT03071900 2017-03-07

CTC Detection Rate in SCCHN With a in Vivo Device

Phase NA Unknown

50 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Neoplastic Cells, Circulating

NCT02505139 2016-08-29

The Value of Diagnosis and Outcome Prediction in CTC for Metastatic NPC Patients

Completed

166 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, Neoplastic Cells, Circulating

NCT01884129 2015-12-10

CTCHNSCC01

Terminated

53 enrolled

Head & Neck

Carcinoma, Squamous Cell, Death, Head and Neck Neoplasms, Neoplastic Cells, Circulating, Neoplasm Metastasis, Recurrence

NCT02119559 2014-12-03

CIRCUTEC

Phase NA Unknown

115 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Neoplastic Cells, Circulating

Clinical Trials

CTCO

Establishment of a Microfluidic Based Liquid Biopsy Platform for Recurrent/Metastatic Head and Neck Cancers Prognostication Using NK Cell IFN-γ Expression and CTM Correlation With DS-SACA Chip

Predicting Clinical Efficacy of Immunotherapy Using Pre-treatment andContinuousMonitoring of PD-L1 TPS/CPS on CTCs, and Immunity Exhaustion Scores

Detecting Chemosensitivity and Predicting Treatmemt Efficacy With CTCs in mNPC

Using a 3D Culture Model for Circulating Tumor Cells Combined With Molecular Bioassays in Patients With HNSCC Cancer

CTCs

WGA in Platinum-refractory HNSCC Underwent Nivolumab

CTC

CTCVADS

The Clinical Relevance of P16 Expressing CTCs Detection Comparing With HPV Infection in Cancer Tissue in HNSCC Patients.

CTC Detection Rate in SCCHN With a in Vivo Device

The Value of Diagnosis and Outcome Prediction in CTC for Metastatic NPC Patients

CTCHNSCC01

CIRCUTEC